Home > Compound List > Product Information
Trimeprazine_Molecular_structure_CAS_84-96-8)
Click picture or here to close

Trimeprazine

Catalog No. DB01246 Name DrugBank
CAS Number 84-96-8 Website http://www.ualberta.ca/
M. F. C18H22N2S Telephone (780) 492-3111
M. W. 298.44568 Fax (780) 492-1071
Purity Email david.wishart@ualberta.ca
Storage Chembase ID: 1115

SYNONYMS

IUPAC name
dimethyl[2-methyl-3-(10H-phenothiazin-10-yl)propyl]amine
IUPAC Traditional name
spansule
Brand Name
Doxergan
Alimezine
Dysedon
Imakol
Levoprome
Panectyl
Temaril
Dosegran
Repeltin
Repetin
Teralen
Theralene
Vallergan
Synonyms
Alimemazine S,S-dioxide
Oxomemazine
Methylpromazine
Alimemazine
Oxomemazina [INN-Spanish]
(+-)-Alimemazine
Oxomemazin
Trimeprazine 5,5-dioxide
Trimeprazine hemi-(+)tartrate
Trimeprazine Tartrat
(+-)-Trimeprazine
Bayer 1219
Oxomemazine [DCF:INN]
Oxomemazinum [INN-Latin]
Oxymemazine
Trimeperazine
Trimeprazine Tartrate

DATABASE IDS

CAS Number 84-96-8
PubChem CID 5574
PubChem SID 46508449

PROPERTIES

Hydrophobicity(logP) 4.6
Solubility 0.942 mg/L

DETAILS

Description (English)
Item Information
Drug Groups approved
Description A phenothiazine derivative that is used as an antipruritic. [PubChem]
Indication Used to prevent and relieve allergic conditions which cause pruritus (itching) and urticaria (some allergic skin reactions).
Pharmacology Trimeprazine (also known as Alimemazine) is a tricyclic antihistamine, similar in structure to the phenothiazine antipsychotics, but differing in the ring-substitution and chain characteristics. Trimeprazine is in the same class of drugs as chlorpromazine (Thorazine) and trifluoperazine (Stelazine); however, unlike the other drugs in this class, trimeprazine is not used clinically as an anti-psychotic. It acts as an anti-histamine, a sedative, and an anti-emetic (anti-nausea). Trimeprazine is used principally as an anti-emetic, to prevent motion sickness or as an anti-histamine in combination with other medications in cough and cold preparations. Tricyclic antihistamines are also structurally-related to the tricyclic antidepressants, explaining the antihistaminergic adverse effects of these two drug classes and also the poor tolerability profile of tricyclic H1-antihistamines.
Toxicity Symptoms of overdose clumsiness or unsteadiness, seizures, severe drowsiness, flushing or redness of face, hallucinations, muscle spasms (especially of neck and back), restlessness, shortness of breath, shuffling walk, tic-like (jerky) movements of head and face, trembling and shaking of hands, and insomnia.
Affected Organisms
Humans and other mammals
Biotransformation Hepatic
Absorption Well absorbed in the digestive tract.

REFERENCES